PUBLIC CONTRACT · 2024
Aquisição de BELIMUMAB IV 400MG PO SOL INJ ao abrigo do CPA 2023/491 para a ULSASI para o ano de 2024
- Contract value
- €4,322.20
- Signed on
- 30 September 2024
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 10945079PUBLISHED SUBJECT
Aquisição de BELIMUMAB IV 400MG PO SOL INJ ao abrigo do CPA 2023/491 para a ULSASI para o ano de 2024
Parties involved
- Place of performance
- Portugal, Lisboa, Amadora
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- GLAXOSMITHKLINE-PROD. FARMACÊUTICOS, LDA. · Tax ID 500139962
Values and timeline
- Contract price
- €4,322.20
- Procedure base price
- €4,322.20
- Total effective price
- Not reported on Portal BASE
- Publication date
- 1 October 2024
- Award date
- 30 September 2024
- Signing date
- 30 September 2024
- Performance period
- 106 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Monofator
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
- Framework agreement
- 491/2023 - Concurso público internacional para formação do acordo quadro de medicamentos do foro oncológico e imunomoduladores
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 7207613
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.